Chinese 拉尼兰诺 Cited by user Leiem on 23 Nov 2023 拉尼兰诺是一种泛PPAR激动剂,是第一种同时针对PPAR-α、PPAR-β和PPAR-γ的靶向药物. 截至2023年,正在进行非酒精性脂肪性肝炎的III期试验;与针对相同病症进行III期试验的其他药物相比,其优势在于它对脂肪性肝炎和纤维化都有改善作用.
English Lanifibranor Cited by user Buidhe on 17 Sep 2023 Lanifibranor is a pan-PPAR (peroxisome proliferator-activated receptor) receptor agonist and is the first medication that targets PPAR-alpha, PPAR-beta, and PPAR-gamma…